1. Home
  2. LTRY vs ADXN Comparison

LTRY vs ADXN Comparison

Compare LTRY & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRY
  • ADXN
  • Stock Information
  • Founded
  • LTRY 2015
  • ADXN 2002
  • Country
  • LTRY United States
  • ADXN Switzerland
  • Employees
  • LTRY N/A
  • ADXN N/A
  • Industry
  • LTRY Computer Software: Prepackaged Software
  • ADXN Biotechnology: Pharmaceutical Preparations
  • Sector
  • LTRY Technology
  • ADXN Health Care
  • Exchange
  • LTRY Nasdaq
  • ADXN Nasdaq
  • Market Cap
  • LTRY N/A
  • ADXN 11.3M
  • IPO Year
  • LTRY N/A
  • ADXN N/A
  • Fundamental
  • Price
  • LTRY $0.49
  • ADXN $11.26
  • Analyst Decision
  • LTRY
  • ADXN Strong Buy
  • Analyst Count
  • LTRY 0
  • ADXN 1
  • Target Price
  • LTRY N/A
  • ADXN $30.00
  • AVG Volume (30 Days)
  • LTRY 52.0K
  • ADXN 24.7K
  • Earning Date
  • LTRY 11-29-2024
  • ADXN 11-11-2024
  • Dividend Yield
  • LTRY N/A
  • ADXN N/A
  • EPS Growth
  • LTRY N/A
  • ADXN N/A
  • EPS
  • LTRY N/A
  • ADXN 0.05
  • Revenue
  • LTRY $5,723,382.00
  • ADXN $960,641.00
  • Revenue This Year
  • LTRY N/A
  • ADXN N/A
  • Revenue Next Year
  • LTRY N/A
  • ADXN N/A
  • P/E Ratio
  • LTRY N/A
  • ADXN $1.87
  • Revenue Growth
  • LTRY 125.44
  • ADXN N/A
  • 52 Week Low
  • LTRY $0.50
  • ADXN $5.00
  • 52 Week High
  • LTRY $7.01
  • ADXN $27.90
  • Technical
  • Relative Strength Index (RSI)
  • LTRY 34.24
  • ADXN 64.36
  • Support Level
  • LTRY $0.51
  • ADXN $10.04
  • Resistance Level
  • LTRY $0.57
  • ADXN $10.81
  • Average True Range (ATR)
  • LTRY 0.03
  • ADXN 0.63
  • MACD
  • LTRY 0.01
  • ADXN 0.08
  • Stochastic Oscillator
  • LTRY 0.00
  • ADXN 86.17

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: